China’s Vaccine Maker Requests Public Use Of Covid Shot



[ad_1]

CHINA-HEALTH-VIRUS

A leadership The Chinese vaccine developer has It applied for authorization to bring its Covid-19 injection to market, seeking to take a leap over its Western rivals as the race for a working vaccine against the virus enters the home stretch.

China National Biotec Group Co. has submitted a request to Chinese regulators, state media Xinhua Finance reported on Wednesday, citing the deputy general manager of parent company Sinopharm, Shi Shengyi. The app is likely to include interim data from the company’s Phase III human trials conducted in the Middle East and South America.

Shares related to Sinopharm Group, including its Hong Kong unit, rose on Wednesday after the news.

A CNBG spokeswoman said she had no further information when contacted by Bloomberg. Calls to the Sinopharm Group went unanswered.

[ad_2]